학술논문

Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): a randomised, open-label, non-inferiority study.
Document Type
Academic Journal
Source
Lancet (LANCET), 6/15/2013; 381(9883): 2091-2099. (9p)
Subject
Language
English
ISSN
0140-6736